查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702113

前列腺癌治疗市场报告（按药物类型（化疗、生物疗法、荷尔蒙疗法等）、配销通路（医院药房、药房和零售药房、线上药房）和地区）2025 年至 2033 年

Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024年全球前列腺癌治疗市场规模达81亿美元。展望未来， IMARC Group预计到2033年市场规模将达到124亿美元，2025-2033年期间的成长率（CAGR）为4.9%。前列腺疾病盛行率的不断上升、个人化医疗的进步、新疗法的出现、医疗保健支出的增加以及公众对前列腺健康和可用治疗方案的认识的不断提高，都在促进市场的成长。

前列腺癌是一种严重的恶性肿瘤，是由男性前列腺内各种异常细胞不受控制地分裂、增殖引起的。可以透过使用各种疗法来治疗，例如疫苗、药物和治疗。其中，化疗、免疫疗法、冷冻疗法、手术、荷尔蒙疗法、标靶疗法和放射疗法是一些最常见的治疗类型，有助于减轻体内癌细胞的扩散。这些疗法是根据各种评估结果提供给患者的，例如患者的年龄、所经历症状的严重程度、医疗状况和既往健康史。

前列腺癌治疗市场趋势：

摄护腺癌盛行率的不断上升，尤其是在老年人口不断增加的情况下，是目前推动市场成长的主要因素之一。同时，优惠的医疗报销政策以及多个国家的政府机构为引入患者援助计划（PAP）而采取的众多倡议也成为其他增长推动因素。 PAP 是一个有组织的项目，由製药公司控制，透过提供免费药物用于治疗来为患者提供经济援助。此外，重大技术进步也促进了市场成长，例如将多参数磁振造影 (mp-MRI) 设备与非转移性去势抗性 (nmCRPC) 和转移性荷尔蒙阴性 (mHNPC) 设定相结合，用于在早期检测前列腺癌，同时减少诊断错误。此外，对研发 (R&D) 活动的大量投资以推出新型治疗产品，以及这些产品在各种线上和线下分销管道上的便捷供应，为市场创造了积极的前景。

本报告回答的关键问题

  • 2024 年全球前列腺癌治疗市场规模？ 2025 年至 2033 年期间全球前列腺癌治疗市场的预期成长率为何？
  • 推动全球前列腺癌治疗市场发展的关键因素有哪些？
  • COVID-19 对全球前列腺癌治疗市场有何影响？
  • 根据药物类型，全球前列腺癌治疗市场是如何分布的？
  • 根据配销通路，全球前列腺癌治疗市场如何分布？
  • 全球前列腺癌治疗市场的关键区域有哪些？
  • 全球前列腺癌治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球前列腺癌治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药物类型

  • 化疗
  • 生物治疗
  • 荷尔蒙疗法
  • 其他的

第七章：市场区隔：按配销通路

  • 医院药房
  • 药局和零售药房
  • 网路药局

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Astellas Pharma Inc.
    • AstraZeneca plc
    • Bayer Aktiengesellschaft
    • Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • GlaxoSmithKline Plc
    • Ipsen (Mayroy SA)
    • Novartis International AG
    • Takeda Pharmaceutical Company Ltd.
    • Tolmar Pharmaceuticals Inc.
Product Code: SR112025A6185

The global prostate cancer treatment market size reached USD 8.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing prevalence of the disease, advancements in personalized medicine, the emergence of new therapies, higher healthcare spending, and growing public awareness about prostate health and available treatment options are strengthening the market growth.

Prostate cancer is a type of severe malignant tumor, which is caused by the uncontrollable division and expansion of various abnormal cells in the prostate gland present in men. It can be treated through the use of various therapeutics, such as vaccines, medications, and treatments. Amongst these, chemotherapy, immunotherapy, cryotherapy, surgery, hormonal, targeted and radiation therapy are some of the most common treatment types that aid in mitigating the spread of cancer cells in the body. These therapies are provided to the patient based on various assessments, such as the age of the patient, severity of the symptoms experienced, medical condition, and previous health history.

Prostate Cancer Treatment Market Trends:

The increasing prevalence of prostate cancer, especially amongst the rising geriatric population, is one of the prime factors currently driving the market toward growth. In line with this, the availability of favorable medical reimbursement policies and the numerous initiatives being undertaken by the government bodies of several countries for introducing patient assistance programs (PAPs) are acting as other growth-inducing factors. PAP is an organized program, which is controlled by pharmaceutical companies for providing financial assistance to patients by offering free medications for treatment purposes. Moreover, significant technological advancements, such as the integration of multiparametric-magnetic resonance imaging (mp-MRI) devices with non-metastatic castration-resistant (nmCRPC) and metastatic hormone nave (mHNPC) settings for detecting prostate cancer at early stages, while mitigating diagnostic errors, is also contributing to the market growth. Additionally, extensive investments in the research and development (R&D) activities to introduce novel therapeutic products, along with their easy availability across various online and offline distribution channels, are creating a positive outlook for the market.

Key Market Segmentation:

Breakup by Drug Type:

  • Chemotherapy
  • Biological Therapy
  • Hormone Therapy
  • Others

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., AstraZeneca plc, Bayer Aktiengesellschaft, Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.), F. Hoffmann-La Roche AG, Ferring B.V., GlaxoSmithKline Plc, Ipsen (Mayroy SA), Novartis International AG, Takeda Pharmaceutical Company Ltd. and Tolmar Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global prostate cancer treatment market in 2024?
  • 2.What is the expected growth rate of the global prostate cancer treatment market during 2025-2033?
  • 3.What are the key factors driving the global prostate cancer treatment market?
  • 4.What has been the impact of COVID-19 on the global prostate cancer treatment market?
  • 5.What is the breakup of the global prostate cancer treatment market based on drug type?
  • 6. What is the breakup of the global prostate cancer treatment market based on the distribution channel?
  • 7.What are the key regions in the global prostate cancer treatment market?
  • 8.Who are the key players/companies in the global prostate cancer treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prostate Cancer Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 Chemotherapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hormone Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospitals Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Drug Stores and Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Astellas Pharma Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AstraZeneca plc
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Bayer Aktiengesellschaft
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Dendreon Pharmaceuticals LLC. (Sanpower Group Co. Ltd.)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Ferring B.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 GlaxoSmithKline Plc
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Ipsen (Mayroy SA)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis International AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Takeda Pharmaceutical Company Ltd.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Tolmar Pharmaceuticals Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prostate Cancer Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Prostate Cancer Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Prostate Cancer Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Prostate Cancer Treatment Market: Breakup by Drug Type (in %), 2024
  • Figure 5: Global: Prostate Cancer Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Prostate Cancer Treatment Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Prostate Cancer Treatment (Chemotherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Prostate Cancer Treatment (Chemotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Prostate Cancer Treatment (Biological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Prostate Cancer Treatment (Biological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Prostate Cancer Treatment (Hormone Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Prostate Cancer Treatment (Hormone Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Prostate Cancer Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Prostate Cancer Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Prostate Cancer Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Prostate Cancer Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Prostate Cancer Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Prostate Cancer Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: North America: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: North America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: United States: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: United States: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Canada: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Canada: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Asia-Pacific: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Asia-Pacific: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: China: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: China: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Japan: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Japan: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: India: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: South Korea: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: South Korea: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Australia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Australia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Indonesia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Indonesia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Europe: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Europe: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Germany: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Germany: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: France: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: France: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United Kingdom: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United Kingdom: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Italy: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Italy: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Spain: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Spain: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Russia: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Russia: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Latin America: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Latin America: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Brazil: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Brazil: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Mexico: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Mexico: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Middle East and Africa: Prostate Cancer Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Middle East and Africa: Prostate Cancer Treatment Market: Breakup by Country (in %), 2024
  • Figure 69: Middle East and Africa: Prostate Cancer Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Global: Prostate Cancer Treatment Industry: SWOT Analysis
  • Figure 71: Global: Prostate Cancer Treatment Industry: Value Chain Analysis
  • Figure 72: Global: Prostate Cancer Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prostate Cancer Treatment Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Prostate Cancer Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 3: Global: Prostate Cancer Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Prostate Cancer Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Prostate Cancer Treatment Market: Competitive Structure
  • Table 6: Global: Prostate Cancer Treatment Market: Key Players